E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Alembic Pharmaceuticals announces USFDA final approval for Dapsone Gel, 5% and Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.
dineshwori
The Ministry of Health and Family Welfare (MoHFW) has proposed amendments to the Drugs Rules, 1945 to introduce acknowledgement-based system for import of drugs for analytical and non-clinical testing.
imphoenix82
Zydus Lifesciences and Sunshine Healthcare have established a joint venture company to establish a pharma manufacturing facility in Sri Lanka.
imphoenix82
Intelivation Technologies plans to collaborate with surgeon partners while generating post-market clinical data to further evaluate the device performance.
imphoenix82
Alongside the portable oxygen concentrator, Dynarex has expanded its Resp-O₂ closed suction catheter range with new models developed specifically for infant and peadiatric patients.
imphoenix82
The acquisition of Advanced Medical Solutions will expand H.B. Fuller’s capabilities across tissue bonding adhesives, tapes and dressings and formulated biosurgicals.
imphoenix82
Haier Biomedical launched the HAB80-60KA / HAB80-60KB automated ultra-low temperature sample storage system at the Europe Biobank Week 2026, while at Interphex Week Tokyo 2026, the company unveiled the DWL368BPST ultra-low temperature freezer designed for laboratories with limited space.
imphoenix82
Under amended Drug Rules, manufacturers of vaccines, antimicrobials, narcotic and psychotropic drugs, and anti-cancer medicines will be required to print or affix a Bar Code or Quick Response (QR) Code on the packaging label.
imphoenix82
As part of the Jan Vishwas reforms, five provisions of the Clinical Establishments Act, 2010 were rationalised. Read on to know the changes…
imphoenix82
The US Food and Drug Administration (FDA) has approved Pfizer’s IBRANCE (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy as a maintenance treatment for adults with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) locally advanced or metastatic breast cancer following induction treatment. IBRANCE is an oral inhibitor of […]
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
